Masimo Investor Day: December 3, 2025 – Live Webcast and In-Depth Business Review

Masimo (NASDAQ: MASI), a leader in medical device innovation, is organizing a comprehensive investor and analyst meeting scheduled for December 3, 2025, at 9:00am PT. The global medical technology company will provide an in-depth look at its business strategy, market expansion opportunities, research and development pipeline, commercial growth initiatives, and long-term financial projections during the event.

Event Details and Access

The gathering will feature presentations from key members of Masimo’s senior management team. Investors worldwide can participate through a live webcast accessible via Masimo’s investor relations hub, located in the “Events and Presentations” section of the company’s website. Alternatively, attendees may access the webcast directly through a dedicated link provided by the company. Following the conclusion of the meeting, both a replay of the webcast and accompanying slide materials will be published on the corporate website for future reference.

For those seeking in-person participation, registration is mandatory and attendance is limited to invited guests only.

About Masimo and Its Market Position

Masimo stands as a prominent global medical technology enterprise specializing in the development and manufacturing of sophisticated monitoring solutions. The company’s portfolio includes cutting-edge measurement technologies, advanced sensors, patient monitoring systems, automation platforms, and integrated connectivity tools designed to enhance clinical workflows.

The organization’s flagship technology, Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry—unveiled in 1995—has demonstrated superior performance compared to competing pulse oximetry systems across more than 100 independent clinical evaluations. Current estimates suggest that Masimo SET® technology monitors over 200 million patients globally on an annual basis and serves as the standard pulse oximetry solution at all 10 hospitals ranked among America’s top medical institutions in the 2025 Newsweek World’s Best Hospitals survey.

For comprehensive information regarding Masimo, its innovations, and investor relations updates, interested parties may visit the company’s official website.

Contact Information:

• Investor Relations: Eli Kammerman, (949) 297-7077, ekammerman@masimo.com
• Media Inquiries: Evan Lamb, (949) 396-3376, elamb@masimo.com